About securitytradeideas

Our mission at Security Trade Ideas (STI) is to provide our readers with profitable Security Trade Ideas and to gain their trust by providing reliable and trustworthy financial information. We want to save you research time and money to enable you to manage your own portfolio. Our passion is to research and to find Security Trade Ideas. We would like to help our readers prosper.

ETF News

Share This:Indian, Russian ETFs triumph over rivals in May 2014 Analysts at ETF.com suggest the best option among small-cap Indian ETFs is the Market Vectors India Small-Cap Index ETF SCIF -1.98%, and for a broader India play, they favor the iShares MSCI India ETF INDA -1.67%. The Market Vectors Russia ETFRSX -1.08% is their top pick among Russian ETFs. What … Continue reading

Security Highlights 06/18/2014

Share This:U.S. RESEARCH ROUNDUP-Adobe Systems, Covidien, Western Union, Halliburton 11:24 AM ET, 06/18/2014 – Reuters June 18 (Reuters) – Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, Covidien and Marriott International, on Wednesday. HIGHLIGHTS Apple : SocGen raises to buy from hold … Continue reading

Options

Share This: According to Barron’s June 16, 2014 reporting: Here are some Equity Options with high Open Interest figures as of close of Business On Thursday June 12, 2014 are: Apple Inc. (AAPL) July 100.00 Call Facebook, Inc. (FB) June 65.00 Call iShares MSCI Emerging Markets (EEM) July 42.50 Puts & … Continue reading

Security Highlights 06/17/2014

Share This:U.S. RESEARCH ROUNDUP-Apple, Oracle, SanDisk, Medtronic, Yahoo 11:23 AM ET, 06/17/2014 – Reuters • June 17 (Reuters) – Wall Street securities analysts revised their ratings and price targetson several U.S.-listed companies, including Oracle, SanDisk and Apple Inc, on Tuesday. HIGHLIGHTS • Agnico Eagle Mines : BMO resumes coverage with … Continue reading

Security Highlights 06/16/2014

Share This:9:29 AM ET, 06/16/2014 – Street Insider bluebird bio, Inc. (Nasdaq: BLUE) 63.3% HIGHER; released initial positive clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy. Covidien … Continue reading